OXFORD, UK--In the first collaboration with its recently formed associate company Cambridge Combinatorial Ltd., Oxford Molecular Group has reached an agreement to jointly provide technical services and consulting in drug design and combinatorial chemistry to Dainippon Pharmaceuticals Co. of Japan for a period of at least a year. The two companies will also help Dainippon establish its own combinatorial chemistry group.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.